A boy and his dog, living with Duchenne together
The story of a boy and his dog is one we all know well. But with David and Bandit, it is a friendship that goes much deeper. It was 2012 when David was diagnosed with Duchenne muscular dystrophy. He was just 3 years old. As his disease progressed, his family knew David needed help to cope with the new challenges. But with his service dog, Bandit, David got so much more. From playing sledge hockey to building Legos to making new friends, David and Bandit have become inseparable.
With a mission to cure Duchenne muscular dystrophy, CureDuchenne breaks the traditional charitable mold and balances passion with business acumen. Our innovative venture philanthropy model funds groundbreaking research, early diagnosis and treatment access. With pioneering education and support programs, our organization drives real change for those with Duchenne muscular dystrophy and their loved ones.
Your Dollar Counts
81% of every dollar goes to research and mission critical programs.
Funding Critical Clinical Trials
12 projects funded by CureDuchenne have progressed to clinical trials.
Making an Impact
We’ve raised over $35 million for research, education and care.
Accelerating a Cure
CureDuchenne contributed early funding for the first FDA-approved Duchenne drug.
Working Towards the Future
Our model has leveraged $2.3 billion in follow-on funding for future programs from investors and biotech companies.
Help us reach $300,000 in 3 months
Your generosity will help fund next generation gene therapy research
that could save those living with Duchenne.
But David isn’t alone. Across the globe, 300,000 boys and young men are facing Duchenne. A devastating, progressive muscle-wasting disease, Duchenne attacks the body’s ability to keep muscle cells intact. Many boys are wheelchair-bound by 12 and few survive beyond their 20s.
But you can help. By donating to CureDuchenne, you can support our efforts to find a cure for Duchenne and save this generation of boys.